Dyne Therapeutics Closes $431.4 Million Upsized Public Offering of Common Stock

Leila Ahmed North America Legal Chronicle
Tagged:

WilmerHale has advised Dyne Therapeutics. Cooley LLP has advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on genetically driven neuromuscular diseases, has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here